Performance of the 808-nm Diode Laser on Equine Upper Airway Tissue Is Enhanced by Intravenous Administration of Indocyanine Green

Objective: The objective was to develop a protocol whereby 808-nm diode laser irradiation combined with intravenous (IV) indocyanine green (ICG) could be used in non-contact mode with equal surgical efficacy to the Nd:YAG on equine tissues. Background Data: The 808-nm diode laser, delivering 20–40 W of power, has been produced for veterinary medical applications. This laser's power output is less than that of most neodymium:yttrium-aluminum-garnet (Nd:YAG) lasers. ICG is absorbed at a wavelength of 810 nm, which when concentrated in tissue should be an excellent absorber for the energy produced by the 808-nm diode laser. Methods: This study compares the depths and widths of thermal penetration achieved with the 808-nm diode laser in equine respiratory tissue after intravenous injection of ICG. ICG was administered at two doses: 1.5 mg/kg and 3 mg/kg. The 808-nm diode laser and Nd:YAG laser were set to deliver 200 J of energy. The depths and widths of thermal penetration obtained were compared. Results: Lesion depth and width tended to be greater in the ICG + 3 mg/kg group than in the ICG + 1.5 mg/kg group. Even so, the 1.5-mg/kg dose substantially increased the efficacy of the diode laser. Plasma ICG concentrations peaked at 5 min post-administration and then dropped markedly; lesion depth decreased after peaking at 7 min post-administration. Conclusion: This study demonstrated that the 808-nm diode laser, when augmented with intravenous ICG, will be as effective a surgical tool as the Nd:YAG laser on equine upper airway tissues when applied using a non-contact fiber.